Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study

Movement Disorders

Volumn 25, Issue 7, 2010, Pages 882-887

  Diederich, Nico J ^a   Pieri, Vannina ^a   Hipp, Géraldine ^a   Rufra, Olivier ^a   Blyth, Sara ^a   Vaillant, Michel ^b  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Hyposmia; Nonmotor signs; Parkinson's disease; REM sleep atonia; Visual deficits

Indexed keywords

BROMOCRIPTINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISCRIMINANT ANALYSIS; DISEASE DURATION; DYSAUTONOMIA; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPOSMIA; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SLEEP DISORDER; VISUAL FIELD DEFECT;

EID: 77951958926     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22963     Document Type: Article

References (29)

1. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-851.
2. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181.
3. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004;19:1196-1201.
4. Doty RL, Shaman P, Applebaum SL, et al. Smell identification ability: changes with age. Science 1984;246:1441-1443.
5. Büttner T, Kuhn W, Müller T, et al. Distorted color discrimination in 'de novo'parkinsonian patients. Neurology 1995;45:386-387.
6. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.
7. Goldstein DS. Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res 2006;16:46-54.
8. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson's disease. Neurology 2005;65:1239-1245.
9. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinson's disease. Brain 2009;132:1128-1145.
10. Nguyen-Legros J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 1988;10:137-144.
11. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophtalmol Vis Sci 1990;31:2473-2475.
12. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004;44:2793-2797.
13. Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009;127:737-741.
14. Devos D, Tir M, Maurage CA, et al. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology 2005;65:1107-1110.
15. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res 1997;37:3509-3529.
16. Bodis-Wollner I, Tzelepi A. The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptors ligands on the pattern electroretinogram. Vision Res 1998;38:1479-1487.
17. Bohnen NI, Minoshima S, Giordani B, et al. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999;52:541-546.
18. Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-422.
19. Braak H, Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
20. Doty RL. The olfactory vector hypothesis of neurodegenerative diseases: is it viable. Ann Neurol 2008;63:7-15.
21. Silveira-Moriyama L, Petrie A, Williams DR, et al. The use of a color coded probability scale to interpret smell tests in suspected Parkinsonism. Mov Disord 2009;24:1144-1153.
22. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
23. Kamei S, Hara M, Serizawa K, et al. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease. Mov Disord 2008;24:566-573.
24. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPalGN study. Brain 2004;127:550-560.
25. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1182-1187.
26. Gagnon JF, Bédard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-589.
27. Stiasny-Kolster K, Mayer G, Schäfer S, et al. The REM sleep behavior disorder screening questionnaire - a new diagnostic instrument (p NA). Mov Disord 2007;22:2386-2393.
28. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-462.
29. Verbaan D, Marinus J, Visser M, et al. Patient-reported autonomic symptoms in Parkinson's disease. Neurology 2007;69:333-341.